Table 3. 20 survival mechanisms that can be either up- or downregulated.
| Biological mechanism | Up | Down | Total |
|---|---|---|---|
| Reactome class A1 rhodopsin like receptors | 8 | 8 | 16 |
| Homeostatic process | 7 | 8 | 15 |
| Reactome G alpha I signaling events | 8 | 7 | 15 |
| Reactome gpcr ligand binding | 11 | 7 | 18 |
| Regulation of developmental process | 6 | 9 | 15 |
| Kegg cytokine cytokine receptor interaction | 6 | 8 | 14 |
| Negative regulation of developmental process | 6 | 6 | 12 |
| Regulation of signal transduction | 6 | 6 | 12 |
| Regulation of multicellular organismal process | 7 | 6 | 13 |
| Reactome peptide ligand binding receptors | 10 | 6 | 16 |
| Regulation of biological quality | 11 | 6 | 17 |
| Positive regulation of immune response | 5 | 12 | 17 |
| T cell activation | 5 | 12 | 17 |
| Reactome hemostasis | 5 | 11 | 16 |
| Regulation of cell proliferation | 5 | 11 | 16 |
| T cell differentiation | 5 | 10 | 15 |
| Biocarta NKT pathway | 5 | 9 | 14 |
| Cytokine activity | 5 | 8 | 13 |
| Cytokine binding | 5 | 8 | 13 |
| Kegg regulation of actin cytoskeleton | 5 | 8 | 13 |
The table shows 20 frequent biological mechanisms across combinations of survival markers that can be either up- or downregulated depending of the particular case.